Patel Samir Rashmikant

Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗

Lifetime net: $0

Positions by company

Reported holding is the most recent post-transaction share count on a Table I row.

Every company this insider has reported trading in, with the value bought and sold at each and the date they last traded.
Ticker	Company	Bought	Sold	Net	Shares held	Last trade
AKTX	Akari Therapeutics Plc	$0	$0	$0	12,102	Oct 5

Akari Therapeutics Plc

Bought

Sold

Held

12,102

How quickly this filer reports. Section 16 allows two business days from the transaction.

2 of 3 filings we hold were filed after the two-business-day deadline. The furthest past the deadline was 39 business days late.

Form 4 filings made after the two-business-day deadline, with the transaction date, the filing date and the number of business days between them.
Traded	Filed	Company	Past deadline	Largest line	Source
Aug 18	Oct 16	AKTXAkari Therapeutics Plc	39days · about 2 months	$49.8K	Filing ↗
Jul 7	Jul 16	AKTXAkari Therapeutics Plc	5days	$249.9K	Filing ↗

Akari Therapeutics Plc

The 14 most recent Form 4 transactions.

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Ticker	Company	Type	Shares	Price	Value	Δ Own	Filing
Oct 5	AKTX	Akari Therapeutics Plc	AGRANT	2,236	$7.90	$17.7K	+22.7%	Open the original filing on SEC.gov
Aug 18	AKTX	Akari Therapeutics Plc	AGRANT◆	15,000	—	—	—